用于研究DNA疫苗的小鼠阴道内单纯疱疹病毒2型攻击模型。
The murine intravaginal HSV-2 challenge model for investigation of DNA vaccines.
作者信息
Marshak Joshua O, Dong Lichun, Koelle David M
机构信息
Department of Medicine, University of Washington, 750 Republican Street, Room E651, Mail Stop 35806, Seattle, WA, 98195, USA.
出版信息
Methods Mol Biol. 2014;1144:305-27. doi: 10.1007/978-1-4939-0428-0_21.
Abstract
DNA vaccines have been licensed in veterinary medicine and have promise for humans. This format is relatively immunogenic in mice and guinea pigs, the two principle HSV-2 animal models, permitting rapid assessment of vectors, antigens, adjuvants, and delivery systems. Limitations include the relatively poor immunogenicity of naked DNA in humans and the profound differences in HSV-2 pathogenesis between host species. Herein, we detail lessons learned over the last few years investigating candidate DNA vaccines in the progesterone-primed female mouse vaginal model of HSV-2 infection as a guide to investigators in the field.
摘要
DNA疫苗已在兽医学中获得许可，并有望应用于人类。这种形式在小鼠和豚鼠这两种主要的HSV - 2动物模型中具有相对较强的免疫原性，能够快速评估载体、抗原、佐剂和递送系统。其局限性包括裸DNA在人类中的免疫原性相对较差，以及宿主物种之间HSV - 2发病机制存在巨大差异。在此，我们详细介绍过去几年在孕激素预处理的雌性小鼠阴道HSV - 2感染模型中研究候选DNA疫苗所获得的经验教训，为该领域的研究人员提供指导。
相似文献
1
The murine intravaginal HSV-2 challenge model for investigation of DNA vaccines.用于研究DNA疫苗的小鼠阴道内单纯疱疹病毒2型攻击模型。
Methods Mol Biol. 2014;1144:305-27. doi: 10.1007/978-1-4939-0428-0_21.
2
The Murine Intravaginal HSV-2 Challenge Model for Investigation of DNA Vaccines.用于研究DNA疫苗的小鼠阴道内单纯疱疹病毒2型攻击模型
Methods Mol Biol. 2020;2060:429-454. doi: 10.1007/978-1-4939-9814-2_27.
3
Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection.布比卡因配制的DNA免疫在单纯疱疹病毒生殖器感染的小鼠和豚鼠模型中的作用
Vaccine. 1999 Apr 9;17(15-16):1964-9. doi: 10.1016/s0264-410x(98)00469-1.
4
Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection.Vaxfectin 佐剂质粒 DNA 疫苗可改善生殖器疱疹感染小鼠模型的保护效果和免疫原性。
J Gen Virol. 2012 Jun;93(Pt 6):1305-1315. doi: 10.1099/vir.0.040055-0. Epub 2012 Mar 7.
5
The efficacy of HSV-2 vaccines based on gD and gB is enhanced by the addition of ICP27.基于 gD 和 gB 的 HSV-2 疫苗的功效通过添加 ICP27 得到增强。
Vaccine. 2012 Dec 14;30(52):7529-35. doi: 10.1016/j.vaccine.2012.10.046. Epub 2012 Oct 25.
6
Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.单纯疱疹病毒2型候选疫苗HSV529在小鼠和豚鼠体内的免疫原性、保护效力及非复制状态
PLoS One. 2015 Apr 2;10(4):e0121518. doi: 10.1371/journal.pone.0121518. eCollection 2015.
7
A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.一种双模态单纯疱疹病毒2型疫苗，通过使用糖蛋白C和D亚基抗原诱导强效抗体反应以及包含衣壳和被膜蛋白的腺病毒载体作为T细胞免疫原，用于预防生殖器疱疹。
J Virol. 2015 Aug;89(16):8497-509. doi: 10.1128/JVI.01089-15. Epub 2015 Jun 3.
8
Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.使用蛋白加强免疫来增强DNA免疫的豚鼠针对单纯疱疹病毒2的保护性体液免疫反应。
FEMS Immunol Med Microbiol. 2008 Oct;54(1):18-26. doi: 10.1111/j.1574-695X.2008.00438.x. Epub 2008 Jul 21.
9
A Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes.一种 Vaxfectin(®)-佐剂的单纯疱疹病毒 2 质粒 DNA 疫苗对豚鼠生殖器疱疹模型具有预防和治疗作用。
Vaccine. 2012 Nov 19;30(49):7046-51. doi: 10.1016/j.vaccine.2012.09.057. Epub 2012 Oct 4.
10
Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs.复制缺陷型、重组糖蛋白和DNA疫苗对小鼠和豚鼠单纯疱疹病毒2感染的比较疗效和免疫原性。
J Virol. 2005 Jan;79(1):410-8. doi: 10.1128/JVI.79.1.410-418.2005.
引用本文的文献
1
Characterization of microRNA Expression Profiles of Murine Female Genital Tracts Following and Herpes Simplex Virus Type 2 Co-Infection.单纯疱疹病毒2型感染后小鼠雌性生殖道的微小RNA表达谱特征分析
Microorganisms. 2025 Jul 24;13(8):1734. doi: 10.3390/microorganisms13081734.
2
Small Animal Models to Study Herpes Simplex Virus Infections.小动物模型用于研究单纯疱疹病毒感染。
Viruses. 2024 Jun 27;16(7):1037. doi: 10.3390/v16071037.
3
CCL28 Enhances HSV-2 gB-Specific Th1-Polarized Immune Responses against Lethal Vaginal Challenge in Mice.CCL28增强针对小鼠致死性阴道感染的HSV-2 gB特异性Th1极化免疫反应。
Vaccines (Basel). 2022 Aug 10;10(8):1291. doi: 10.3390/vaccines10081291.
4
Il4ra-independent vaginal eosinophil accumulation following helminth infection exacerbates epithelial ulcerative pathology of HSV-2 infection.寄生虫感染后 IL4ra 非依赖性阴道嗜酸性粒细胞聚集加剧 HSV-2 感染的上皮溃疡性病理。
Cell Host Microbe. 2021 Apr 14;29(4):579-593.e5. doi: 10.1016/j.chom.2021.02.004.
5
Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.单纯疱疹病毒 2 型与 HIV-1 之间的生物学相互作用及其对单纯疱疹病毒疫苗开发的可能影响。
Vaccine. 2019 Nov 28;37(50):7363-7371. doi: 10.1016/j.vaccine.2017.09.044. Epub 2017 Sep 25.
6
A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs.一种新型单纯疱疹病毒2型亚单位疫苗可诱导小鼠和豚鼠产生依赖于GLA的CD4和CD8 T细胞应答及保护性免疫。
Vaccine. 2016 Jan 2;34(1):101-9. doi: 10.1016/j.vaccine.2015.10.137. Epub 2015 Nov 10.
7
Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge.以表达 gB/gD 胞外结构域的人乳头瘤病毒载体进行局部单纯疱疹病毒 2（HSV-2）疫苗接种可诱导生殖器组织驻留记忆 CD8+T 细胞，并减少 HSV-2 挑战后的生殖器疾病和病毒脱落。
J Virol. 2015 Jan;89(1):83-96. doi: 10.1128/JVI.02380-14. Epub 2014 Oct 15.
本文引用的文献
1
Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection.Vaxfectin 佐剂质粒 DNA 疫苗可改善生殖器疱疹感染小鼠模型的保护效果和免疫原性。
J Gen Virol. 2012 Jun;93(Pt 6):1305-1315. doi: 10.1099/vir.0.040055-0. Epub 2012 Mar 7.
2
Efficacy results of a trial of a herpes simplex vaccine.一项单纯疱疹疫苗试验的疗效结果。
N Engl J Med. 2012 Jan 5;366(1):34-43. doi: 10.1056/NEJMoa1103151.
3
HSV-2: in pursuit of a vaccine.单纯疱疹病毒 2 型：追求疫苗。
J Clin Invest. 2011 Dec;121(12):4600-9. doi: 10.1172/JCI57148. Epub 2011 Dec 1.
4
Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses.临床免疫学评论系列；关注宿主反应：T 细胞对单纯疱疹病毒的反应。
Clin Exp Immunol. 2012 Jan;167(1):47-58. doi: 10.1111/j.1365-2249.2011.04502.x.
5
Different patterns of peripheral migration by memory CD4+ and CD8+ T cells.记忆性 CD4+ 和 CD8+ T 细胞的外周迁移的不同模式。
Nature. 2011 Aug 14;477(7363):216-9. doi: 10.1038/nature10339.
6
Evidence for differences in immunologic and pathogenesis properties of herpes simplex virus 2 strains from the United States and South Africa.美国和南非单纯疱疹病毒 2 株在免疫和发病机制特性方面的差异证据。
J Infect Dis. 2011 May 15;203(10):1434-41. doi: 10.1093/infdis/jir047. Epub 2011 Apr 14.
7
Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection.生殖器单纯疱疹病毒在 HSV-2 感染的有症状和无症状者中的脱落情况。
JAMA. 2011 Apr 13;305(14):1441-9. doi: 10.1001/jama.2011.420.
8
A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine.一种减毒的单纯疱疹病毒 2 型 ICP0 病毒在诱导针对生殖器疱疹的保护方面比糖蛋白 D 亚单位疫苗强 10 至 100 倍。
PLoS One. 2011 Mar 11;6(3):e17748. doi: 10.1371/journal.pone.0017748.
9
Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 mice.鉴定 C57BL/6 小鼠体内单纯疱疹病毒特异性 CD8+ T 细胞库。
J Immunol. 2011 Apr 1;186(7):3927-33. doi: 10.4049/jimmunol.1003735. Epub 2011 Feb 25.
10
DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge.密集短微针阵列经皮给药 DNA 疫苗可预防阴道 HSV-2 感染。
Vaccine. 2010 Nov 3;28(47):7483-91. doi: 10.1016/j.vaccine.2010.09.014. Epub 2010 Sep 17.
Zotero 插件